In the present study and the prior literature together, a total of 23 AdCC patients and 3 SDC patients treated with [177Lu]Lu-PSMA have been described, yet no objective responses of [177Lu]Lu-PSMA have been reported in any of these patients. The gene discussed is FOLH1; the disease is adrenocortical carcinoma, hereditary.